Microglia in neurodegenerative disease

V Hugh Perry1, James A R Nicoll, Clive Holmes

  • 1School of Biological Sciences, University of Southampton, Building 62, Boldrewood Campus, Southampton SO16 7PX, UK. v.h.perry@soton.ac.uk

Insights

Microglia, immune cells in the brain, change in response to injury and disease. Their persistent activation suggests an immune memory, impacting neurodegeneration and Alzheimer's disease risk.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglia are the central nervous system's (CNS) resident macrophages.
  • They are highly sensitive to brain injury and disease, adopting an activated state.
  • Activated microglia exhibit diverse phenotypes dependent on injury type and may serve as diagnostic markers.

Purpose of the Study:

  • To explore the role of microglial activation in neurodegenerative diseases.
  • To investigate the concept of innate immune memory in microglia.
  • To examine the influence of systemic inflammation on microglial phenotype and neurodegenerative disease progression.

Main Methods:

  • Analysis of microglial morphology and phenotype changes in response to CNS insults.
  • Review of preclinical models investigating systemic manipulation effects on neurodegeneration.
  • Examination of the association between systemic inflammation and cognitive decline in neurodegenerative disease patients.

Main Results:

  • Microglia alter morphology and phenotype in response to brain injury, indicating diverse functional states.
  • Activated microglia can persist long-term, suggesting an innate immune memory.
  • Systemic inflammation impacts microglial phenotype and is linked to disease progression and Alzheimer's disease risk.

Conclusions:

  • Microglia play a critical role in CNS injury and neurodegenerative diseases.
  • Microglial immune memory is a significant factor in disease pathology.
  • Systemic inflammation and CNS microglia crosstalk influences neurodegeneration and Alzheimer's disease.